Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > 3 DAY RULE
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by PROtradingon Mar 29, 2016 11:06pm
92 Views
Post# 24709556

RE:RE:RE:3 DAY RULE

RE:RE:RE:3 DAY RULE
BaytexBull wrote: [nonsense deleted] ...It will be like a knife through butter from $29 to $24. Good luck PRO!


I don't disagree on this point but I don't agree either. 

Shorts are getting nervous here.  Easy to see. When you start rambling on with garbage, it's telling!

But we are standing "buy" for capitulation (now or in the near future).   That I can tell you for sure.

We love blood on the street.

Good Luck "newly minted" BaytexBull!  LOL!  ;-)



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities